SCHEMBL5500494

SCHEMBL5500494

CCCCc1ccc(CN=C=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ CA2 P00918 3/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ CA1 P00915 1/20 0.44
▸ RARB P10826 1/20 0.43
▸ PLK1 P53350 1/20 0.43
▸ THRA P10827 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ SKP2 Q13309 1/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ ESR1 P03372 2/20 0.41
▸ ADRA2A P08913 2/20 0.41
▸ ADORA3 P0DMS8 2/20 0.41
▸ TACR2 P21452 2/20 0.41
▸ SLC6A2 P23975 2/20 0.41
▸ SLC6A4 P31645 2/20 0.41
▸ SLC6A3 Q01959 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13479749 0.94 ALDH1A1 (0.49) ALDH1A1HSD17B10CA2RARBTHRA
SCHEMBL21089 0.81 MIF (0.44) ALDH1A1HPGDCYP3A4
SCHEMBL4881618 0.81 MIF (0.55) ALDH1A1HSD17B10HPGDCA2SMN1; SMN2
SCHEMBL19832685 0.81 MIF (0.33) ALDH1A1HSD17B10HPGDCYP3A4
SCHEMBL20766276 0.80 KDM4E (0.47) ALDH1A1CA2SMN1; SMN2CA1KDM4E
SCHEMBL1456990 0.79 CYP2A6 (0.41) ALDH1A1HPGDCA2PLK1CYP3A4
SCHEMBL2983108 0.79 NAAA (0.47) ALDH1A1HSD17B10ESR1ADRA2AADORA3
Water SCHEMBL14972874 0.79 MIF (0.43) ALDH1A1HPGDCYP3A4
SCHEMBL22471901 0.79 MIF (0.43) ALDH1A1HPGDCYP3A4
Water SCHEMBL29040332 0.79 MIF (0.43) ALDH1A1HPGDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1861357-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2007-12-05 — — EP disclosed
CN-1863777-A Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor ABBOTT LAB (US) 2006-11-15 — — CN disclosed
WO-2006101318-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2006-09-28 — — WO disclosed
Send feedback